Simplexa® COVID-19 Direct Kit: Diasorin offers FDA-cleared RT-PCR assay for rapid, accurate SARS-CoV-2 detection in symptomatic individuals.

Simplexa® Real-Time PCR: Diasorin provides validated real-time PCR products for precise, multi-analyte detection allowing fast and easy to interpret results.

Simplexa ® C. auris Direct is a qualitative real-time PCR assay with a simple workflow for the in vitro qualitative detection of C. auris DNA from a composite swab of bilateral axilla/groin from patients suspected of C. auris colonization.

The DiaSorin Molecular SimplexaTM COVID-19 Direct assay system is a real-time RT-PCR system that enables the direct amplification of Coronavirus SARS-CoV-2 RNA from nasopharyngeal swabs (NPS ...

Simplexa™ Congenital CMV Direct Kit: Diasorin provides accurate newborn CMV detection via saliva screening and urine confirmation, avoiding false positives.

Rapid results and high-throughput Simplexa™ C. difficile Universal Direct assay for up to 94 patient samples per run with results in about 1 hour.

Simplexa® COVID-19 & Flu A/B Direct: Diasorin provides real-time RT-PCR assay for simultaneous detection of SARS-CoV-2, influenza A, and B in one sample.

What is the SimplexaTM COVID-19 Direct? The test is designed to detect the virus that causes COVID-19 in respiratory specimens, for example nasal or oral swabs. COVID-19. What are the known and...

Based upon the platform and assay’s product configuration, including but not limited to fill volumes and concentrations of analytes, we recommend the following external quality controls and verification panels to be used in conjunction with the Diasorin Simplexa™ system.

Jul 22, 2021 · The Simplexa COVID-19 Direct assay is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.